For UCLA-based startup, new muscular dystrophy treatment is a personal mission
For UCLA-based startup, new muscular dystrophy treatment is a personal mission MyoGene Bio, a finalist in UC Startup Innovation Challenge, is developing a gene therapy for the deadly childhood condition UCLA Wayne Lewis | February 23, 2021 Courtney Young helped develop the gene therapy at the heart of a biotech startup, MyoGene Bio, when she was a doctoral student at UCLA from 2013 to 2018. But the kernel of the company’s endeavor is older still — and definitively personal. In 2008, when Young was in high school, she found out that her cousin, then just a toddler, had been diag...
Source: ucla.edu